BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

599 related articles for article (PubMed ID: 32854276)

  • 1. Molecular and Cellular Mechanisms Affected in ALS.
    Le Gall L; Anakor E; Connolly O; Vijayakumar UG; Duddy WJ; Duguez S
    J Pers Med; 2020 Aug; 10(3):. PubMed ID: 32854276
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetics of amyotrophic lateral sclerosis: an update.
    Chen S; Sayana P; Zhang X; Le W
    Mol Neurodegener; 2013 Aug; 8():28. PubMed ID: 23941283
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanistic Insights of Mitochondrial Dysfunction in Amyotrophic Lateral Sclerosis: An Update on a Lasting Relationship.
    Candelise N; Salvatori I; Scaricamazza S; Nesci V; Zenuni H; Ferri A; Valle C
    Metabolites; 2022 Mar; 12(3):. PubMed ID: 35323676
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proteinopathies as Hallmarks of Impaired Gene Expression, Proteostasis and Mitochondrial Function in Amyotrophic Lateral Sclerosis.
    Benson BC; Shaw PJ; Azzouz M; Highley JR; Hautbergue GM
    Front Neurosci; 2021; 15():783624. PubMed ID: 35002606
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Extracellular Vesicles in Amyotrophic Lateral Sclerosis.
    McCluskey G; Morrison KE; Donaghy C; Rene F; Duddy W; Duguez S
    Life (Basel); 2022 Dec; 13(1):. PubMed ID: 36676070
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mitochondrial dysfunction in amyotrophic lateral sclerosis.
    Shi P; Gal J; Kwinter DM; Liu X; Zhu H
    Biochim Biophys Acta; 2010 Jan; 1802(1):45-51. PubMed ID: 19715760
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amyotrophic Lateral Sclerosis, FUS and Protein Synthesis Defects.
    Assoni AF; Foijer F; Zatz M
    Stem Cell Rev Rep; 2023 Apr; 19(3):625-638. PubMed ID: 36515764
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dysregulation of the autophagy-endolysosomal system in amyotrophic lateral sclerosis and related motor neuron diseases.
    Otomo A; Pan L; Hadano S
    Neurol Res Int; 2012; 2012():498428. PubMed ID: 22852081
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amyotrophic Lateral Sclerosis Risk Genes and Suppressor.
    Kumar R; Malik Z; Singh M; Rachana R; Mani S; Ponnusamy K; Haider S
    Curr Gene Ther; 2023; 23(2):148-162. PubMed ID: 36366843
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endosomal accumulation of APP in wobbler motor neurons reflects impaired vesicle trafficking: implications for human motor neuron disease.
    Palmisano R; Golfi P; Heimann P; Shaw C; Troakes C; Schmitt-John T; Bartsch JW
    BMC Neurosci; 2011 Mar; 12():24. PubMed ID: 21385376
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mitochondrial dysfunction is a converging point of multiple pathological pathways in amyotrophic lateral sclerosis.
    Shi P; Wei Y; Zhang J; Gal J; Zhu H
    J Alzheimers Dis; 2010; 20 Suppl 2():S311-24. PubMed ID: 20463400
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Implications of Selective Autophagy Dysfunction for ALS Pathology.
    Vicencio E; Beltrán S; Labrador L; Manque P; Nassif M; Woehlbier U
    Cells; 2020 Feb; 9(2):. PubMed ID: 32046060
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mitochondrial bioenergetic deficits in C9orf72 amyotrophic lateral sclerosis motor neurons cause dysfunctional axonal homeostasis.
    Mehta AR; Gregory JM; Dando O; Carter RN; Burr K; Nanda J; Story D; McDade K; Smith C; Morton NM; Mahad DJ; Hardingham GE; Chandran S; Selvaraj BT
    Acta Neuropathol; 2021 Feb; 141(2):257-279. PubMed ID: 33398403
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current hypotheses for the underlying biology of amyotrophic lateral sclerosis.
    Rothstein JD
    Ann Neurol; 2009 Jan; 65 Suppl 1():S3-9. PubMed ID: 19191304
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current Concepts on Genetic Aspects of Mitochondrial Dysfunction in Amyotrophic Lateral Sclerosis.
    Jankovic M; Novakovic I; Gamil Anwar Dawod P; Gamil Anwar Dawod A; Drinic A; Abdel Motaleb FI; Ducic S; Nikolic D
    Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34575995
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Redox regulation in amyotrophic lateral sclerosis.
    Parakh S; Spencer DM; Halloran MA; Soo KY; Atkin JD
    Oxid Med Cell Longev; 2013; 2013():408681. PubMed ID: 23533690
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mitochondrial function, morphology, and axonal transport in amyotrophic lateral sclerosis.
    Magrané J; Manfredi G
    Antioxid Redox Signal; 2009 Jul; 11(7):1615-26. PubMed ID: 19344253
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oxidative Stress as a Therapeutic Target in Amyotrophic Lateral Sclerosis: Opportunities and Limitations.
    Park HR; Yang EJ
    Diagnostics (Basel); 2021 Aug; 11(9):. PubMed ID: 34573888
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Role of axonal transport in ALS].
    Tanaka F; Ikenaka K; Sobue G
    Rinsho Shinkeigaku; 2011 Nov; 51(11):1189-91. PubMed ID: 22277530
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Roots to start research in amyotrophic lateral sclerosis: molecular pathways and novel therapeutics for future.
    Harikrishnareddy D; Misra S; Upadhyay S; Modi M; Medhi B
    Rev Neurosci; 2015; 26(2):161-81. PubMed ID: 25720096
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.